BR112015012138A2 - composição, método para obtenção de uma composição, método de formação de imagem in vivo, e, kit - Google Patents
composição, método para obtenção de uma composição, método de formação de imagem in vivo, e, kitInfo
- Publication number
- BR112015012138A2 BR112015012138A2 BR112015012138A BR112015012138A BR112015012138A2 BR 112015012138 A2 BR112015012138 A2 BR 112015012138A2 BR 112015012138 A BR112015012138 A BR 112015012138A BR 112015012138 A BR112015012138 A BR 112015012138A BR 112015012138 A2 BR112015012138 A2 BR 112015012138A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- kit
- obtaining
- vivo imaging
- vivo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3689DE2012 | 2012-11-30 | ||
| GBGB1300647.3A GB201300647D0 (en) | 2013-01-15 | 2013-01-15 | Crystallization |
| PCT/EP2013/074986 WO2014083113A1 (en) | 2012-11-30 | 2013-11-28 | Crystallization process of tricyclic indole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015012138A2 true BR112015012138A2 (pt) | 2017-07-11 |
Family
ID=54266915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015012138A BR112015012138A2 (pt) | 2012-11-30 | 2013-11-28 | composição, método para obtenção de uma composição, método de formação de imagem in vivo, e, kit |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10709798B2 (https=) |
| EP (1) | EP2943195A1 (https=) |
| JP (1) | JP6280560B2 (https=) |
| KR (1) | KR20150088802A (https=) |
| CN (2) | CN111362863A (https=) |
| AU (1) | AU2013351152A1 (https=) |
| BR (1) | BR112015012138A2 (https=) |
| CA (1) | CA2892485A1 (https=) |
| IN (1) | IN2015DN03978A (https=) |
| MX (1) | MX2015006871A (https=) |
| RU (1) | RU2015118217A (https=) |
| WO (1) | WO2014083113A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20150088802A (ko) | 2012-11-30 | 2015-08-03 | 지이 헬쓰케어 리미티드 | 트리시클릭 인돌 유도체의 결정화 방법 |
| US20160144477A1 (en) * | 2014-11-21 | 2016-05-26 | Diane Scott | Coated compressive subpad for chemical mechanical polishing |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6177440B1 (en) * | 1996-10-30 | 2001-01-23 | Eli Lilly And Company | Substituted tricyclics |
| CA2310250A1 (en) | 1997-11-14 | 1999-05-27 | August Masaru Watanabe | Treatment for alzheimer's disease |
| DZ2769A1 (fr) | 1998-04-17 | 2003-12-01 | Lilly Co Eli | Composés tricycliques substitués. |
| US7160909B2 (en) | 2001-08-09 | 2007-01-09 | Eli Lilly And Company | Cyclopenta[b]indole derivatives as sPLA2 inhibitors |
| ATE312817T1 (de) | 2001-08-09 | 2005-12-15 | Lilly Co Eli | Cyclohept'bö indolderivate als spla2-inhibitoren |
| GB0905328D0 (en) | 2009-03-27 | 2009-05-13 | Ge Healthcare Ltd | Indole derivatives |
| JP5830519B2 (ja) | 2010-03-26 | 2015-12-09 | ジーイー・ヘルスケア・リミテッド | Ｐｂｒリガンドとしての三環式インドール誘導体 |
| GB201016038D0 (en) | 2010-09-24 | 2010-11-10 | Ge Healthcare Ltd | In vivo imaging method |
| GB201016411D0 (en) | 2010-09-30 | 2010-11-10 | Ge Healthcare Ltd | In vivo imaging method for cancer |
| GB201021263D0 (en) | 2010-12-15 | 2011-01-26 | Ge Healthcare Ltd | Solid phase extraction method |
| US9220795B2 (en) * | 2011-09-22 | 2015-12-29 | Ge Healthcare Limited | Indole derivatives |
| KR20150088802A (ko) | 2012-11-30 | 2015-08-03 | 지이 헬쓰케어 리미티드 | 트리시클릭 인돌 유도체의 결정화 방법 |
-
2013
- 2013-11-28 KR KR1020157013974A patent/KR20150088802A/ko not_active Withdrawn
- 2013-11-28 WO PCT/EP2013/074986 patent/WO2014083113A1/en not_active Ceased
- 2013-11-28 BR BR112015012138A patent/BR112015012138A2/pt not_active IP Right Cessation
- 2013-11-28 CA CA2892485A patent/CA2892485A1/en not_active Abandoned
- 2013-11-28 MX MX2015006871A patent/MX2015006871A/es unknown
- 2013-11-28 AU AU2013351152A patent/AU2013351152A1/en not_active Abandoned
- 2013-11-28 JP JP2015544462A patent/JP6280560B2/ja active Active
- 2013-11-28 CN CN202010090283.9A patent/CN111362863A/zh active Pending
- 2013-11-28 IN IN3978DEN2015 patent/IN2015DN03978A/en unknown
- 2013-11-28 EP EP13796090.2A patent/EP2943195A1/en not_active Withdrawn
- 2013-11-28 RU RU2015118217A patent/RU2015118217A/ru not_active Application Discontinuation
- 2013-11-28 US US14/648,353 patent/US10709798B2/en active Active
- 2013-11-28 CN CN201380062872.4A patent/CN104837489A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014083113A1 (en) | 2014-06-05 |
| US10709798B2 (en) | 2020-07-14 |
| JP2016507477A (ja) | 2016-03-10 |
| JP6280560B2 (ja) | 2018-02-14 |
| KR20150088802A (ko) | 2015-08-03 |
| CA2892485A1 (en) | 2014-06-05 |
| CN111362863A (zh) | 2020-07-03 |
| AU2013351152A1 (en) | 2015-05-21 |
| RU2015118217A (ru) | 2017-01-11 |
| IN2015DN03978A (https=) | 2015-10-02 |
| CN104837489A (zh) | 2015-08-12 |
| US20150335766A1 (en) | 2015-11-26 |
| EP2943195A1 (en) | 2015-11-18 |
| MX2015006871A (es) | 2015-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6630147A2 (es) | Modificador del sabor dulce | |
| MX2023006541A (es) | Formulaciones de dosis fija. | |
| MX2013001677A (es) | Formulaciones estables de linaclotida. | |
| MY157124A (en) | Substituted imidazopyridinyl-aminopyridine compounds | |
| PH12012501337A1 (en) | Substituted pyrrolo-aminopyrimidine compounds | |
| BR112013007364A2 (pt) | preparação para melhorar a solubilidade para um fármaco pouco solúvel | |
| PH12013502565A1 (en) | Substituted imidazopyridinyl-aminopyridine compounds | |
| WO2011082267A3 (en) | Substituted triazolo-pyrazine compounds | |
| UA109868C2 (ru) | Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar) | |
| MX346147B (es) | Compuestos de 3-aril-5-substituido-isoquinolin-1-ona y su uso terapeutico. | |
| MX2013001234A (es) | Derivados deuterados de tandospirona como agonistas del receptor 5-hidroxitriptamina 1a. | |
| MX362530B (es) | Composiciones de acido hialuronico que comprenden mepivacaina. | |
| WO2013188283A8 (en) | Topical ophthalmological pharmaceutical composition containing sunitinib | |
| WO2015033302A3 (en) | Fulvestrant compositions | |
| BR112015004523A2 (pt) | compostos de tetraciclina | |
| MX2012001691A (es) | Composiciones de linaclotida que se desintegran oralmente. | |
| PH12012501556A1 (en) | Substituted naphthalenyl-pyrimidine compounds | |
| TN2015000280A1 (en) | Topical Ophthalmological Pharmaceutical Composition containing Regorafenib | |
| CA2922375C (en) | Alpha-tea salt forms: compositions and uses for treating disease | |
| EA201600394A1 (ru) | Трициклические соединения пиперидина | |
| BR112015012138A2 (pt) | composição, método para obtenção de uma composição, método de formação de imagem in vivo, e, kit | |
| WO2014006635A3 (en) | Solid oral compositions of silodosin | |
| WO2011082271A3 (en) | Substituted triazolo-pyrimidine compounds | |
| MX362717B (es) | Formulaciones de agomelatina que comprenden agomelatina en forma de cocristales. | |
| TN2014000484A1 (en) | Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |